COVID-19 VACCINE HUMAN TRIAL IN INDIA
NEW DELHI: The trials of the first Indian vaccine for Covid-19 has started Bharat Biotech International Limited said, BBIL which developed India's first potential indigenous COVID-19 vaccine said that testing has begun on 375 people. A report in the newspaper The Hindustan Times said that BBIL said that the human trials of Covaxin started on July 15. The Company has Jointly developed the India's first vaccine along with the Indian Council of Medical Research (ICMR).
Earlier this month, it was reported that the Belagavi Jeevan Sakhi Multi Speciality Hospital would be among the units where the multicity clinical trial of the vaccine would be conducted. Trials would also be conducted at the AIIMS, Delhi and Hyderabad. The trial would be conducted at the Nizam's Institute of Medical Sciences, Hyderabad.
This drug has been developed by the Hyderabad based Bharat Biotech and is known as Covaxin. The drug controller General of India had granted permission to Initiate Phase I and II human clinical trials after the company submitted results generated from the Pre-clinical studies, demonstrating safety and immune response.
During the trial researchers would examine the vaccine's efficiency with a single dose as well a double dose on the 1st and 14th day.
Two day ago corona vaccine trial has been successfully completed on Rat & Rabit and ICMR clarified the Human trial for vaccine. Vaccine Human trial given the good sign in india, russia & america.
As per regards the researchers Covaxin test results
ICMR clarified that August 15 was not a deadline for COVAXIN
On 3 July, ICMR director Balaram Bhargava wrote a letter to Bharat Biotech stating that COVID-19 vaccine-covaxin trials could begin rapidly, with a launch deadline of 15 August. The news stirred up the science industry as it appeared almost impossible. Hurry through the process
To meet the deadline. On Sunday, July 5, the ICMR clarified that it had not set a deadline for the COVID-19 vaccine; Its purpose was to give a message about the vaccine requirement, Said this
Bharat Biotech received a setback on 30 June for clinical human trials of the COVID-19 vaccine, which was developed jointly with ICMR and NIV. The vaccine was to enter global markets by the end of October after undergoing all testing procedures and formalities. After receiving a letter from ICMR to begin the process by 15 August and launch the vaccine in the coming days, the scientists found the timeline unrealistic and believed it would compromise product quality.
However, the ICMR now clarifies that it has not set a time limit for the vaccine. Considering the urgency and uncertainty of the global pandemic, the idea of conducting a clinical trial as soon as possible provoked this. As reported by reported THE MINT '"Our internal communication is being misplaced.
Post a Comment
Have any queries let me know